We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
According to state media, China's drug industry recorded CNY212.5bn (US$26.26bn) in output value in H105, an increase of 23% compared to the same period last year.
Norwood Abbey Limited (OTC:NABYF) (ASX:NAL) today announced that it has reached agreement with US institutional investors to raise US$10 million (approximately A$13.3 million).
Novogen Limited (Nasdaq: NVGN -- News; ASX: NRT -- News) today announced the expansion in the U.S. of Glycotex, Inc., its U.S. subsidiary, and the resignation of Dr. Graham Kelly from Novogen's Board of Directors in order for him to focus on the development and expansion of Novogen's U.S. subsidiary companies.
Domantis Limited, the human Domain Antibody Therapeutics company, has successfully opposed European patent number EP0656946, leading to a major amendment of the main claim in the patent and a significant narrowing of the scope of 34 of the 41 other claims.
Starting January 1, 2006, drug retail sales enterprises nationwide will be prohibited from dealing in a list of drugs, and patients that need these drugs must obtain a prescription from a medical institution.
Chiron Corp.'s largest shareholder, Novartis AG, is offering $4.5 billion to acquire full control of the troubled Emeryville biotechnology firm, which triggered a public health crisis last year when its entire U.S. flu shot inventory was lost to bacterial contamination.